Evidence map›Paper›PMID 31506459›Full record

ArticleScientific reports2019

Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties.

Maria Bogdanova, Arsenii Zabirnyk, Anna Malashicheva, Katarina Zihlavnikova Enayati, Tommy Aleksander Karlsen, Mari-Liis Kaljusto, John-Peder Escobar Kvitting, Erik Dissen, Gareth John Sullivan, Anna Kostareva and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 43 citations in OpenAlex.

  1. Aortic Stenosis Hyalectan Remodeling Revealed by Proteomics and Glycoproteomics.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Multi-omics ofFrontiers in cardiovascular medicine · 2022
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Maria BogdanovaDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. marbogdanova3@gmail.com.ORCID 0000-0001-5006-8634
Arsenii ZabirnykDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Anna MalashichevaAlmazov National Medical Research Centre, Saint Petersburg, Russia.
Katarina Zihlavnikova EnayatiDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Tommy Aleksander KarlsenNorwegian Center for Stem Cell Research, Department of Immunology, Oslo University Hospital, Oslo, Norway.
Mari-Liis KaljustoDepartment of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway.
John-Peder Escobar KvittingDepartment of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway.
Erik DissenDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Gareth John SullivanDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Anna KostarevaAlmazov National Medical Research Centre, Saint Petersburg, Russia.
Kåre-Olav StensløkkenDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.ORCID 0000-0003-2962-4143
Arkady RutkovskiyDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Jarle VaageDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NOKarolinska Institutet · SESt Petersburg University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valve interstitial cells (VICs) are crucial in the development of calcific aortic valve disease. The purpose of the present investigation was to compare the phenotype, differentiation potential and stem cell-like properties of cells from calcified and healthy aortic valves. VICs were isolated from human healthy and calcified aortic valves. Calcification was induced with osteogenic medium. Unlike VICs from healthy valves, VICs from calcified valves cultured without osteogenic medium stained positively for calcium deposits with Alizarin Red confirming their calcific phenotype. Stimulation of VICs from calcified valves with osteogenic medium increased calcification (p = 0.02), but not significantly different from healthy VICs. When stimulated with myofibroblastic medium, VICs from calcified valves had lower expression of myofibroblastic markers, measured by flow cytometry and RT-qPCR, compared to healthy VICs. Contraction of collagen gel (a measure of myofibroblastic activity) was attenuated in cells from calcified valves (p = 0.04). Moreover, VICs from calcified valves, unlike cells from healthy valves had lower potential to differentiate into adipogenic pathway and lower expression of stem cell-associated markers CD106 (p = 0.04) and aldehyde dehydrogenase (p = 0.04). In conclusion, VICs from calcified aortic have reduced multipotency compared to cells from healthy valves, which should be considered when investigating possible medical treatments of aortic valve calcification.

Indexed as

Cell DifferentiationOsteogenesisAortic ValveAortic Valve StenosisBicuspid Aortic Valve DiseaseBiomarkersCalcinosisCells, CulturedFemaleGene Expression ProfilingHeart Defects, CongenitalHeart Valve DiseasesHumansInterstitial Cells of CajalMaleMyofibroblastsBiomarkers

Identifiers

PMID31506459
PMCPMC6736931
OpenAlexW2972824451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.